Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) EBT Margin: 2009-2020

Historic EBT Margin for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2020 value amounting to -82.52%.

  • Avadel Pharmaceuticals' EBT Margin rose 65259.00% to 156.56% in Q4 2020 from the same period last year, while for Dec 2020 it was 24.54%, marking a year-over-year increase of 16198.00%. This contributed to the annual value of -82.52% for FY2020, which is 5492.00% up from last year.
  • As of FY2020, Avadel Pharmaceuticals' EBT Margin stood at -82.52%, which was up 39.96% from -137.44% recorded in FY2019.
  • Avadel Pharmaceuticals' EBT Margin's 5-year high stood at 53.48% during FY2017, with a 5-year trough of -137.44% in FY2019.
  • In the last 3 years, Avadel Pharmaceuticals' EBT Margin had a median value of -109.61% in 2018 and averaged -109.86%.
  • Its EBT Margin has fluctuated over the past 5 years, first spiked by 5,995bps in 2017, then tumbled by 16,310bps in 2018.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' EBT Margin stood at -6.47% in 2016, then skyrocketed by 5,995bps to 53.48% in 2017, then slumped by 16,310bps to -109.61% in 2018, then tumbled by 2,783bps to -137.44% in 2019, then surged by 5,492bps to -82.52% in 2020.